Literature DB >> 10686037

Pseudomonas aeruginosa cross-infection among patients with cystic fibrosis during a winter camp.

B Ojeniyi1, B Frederiksen, N Hoiby.   

Abstract

Twenty-seven patients with cystic fibrosis from our Danish Cystic Fibrosis Center went to a winter camp for 1 week in November of 1990. This study is based on 22 of these patients. Prior to attending camp, 17 out of 22 patients harbored Pseudomonas aeruginosa in their sputum, but 5 patients did not. After returning from camp, all 22 patients harbored P. aeruginosa in the sputum, including the 5 patients whose sputum was free of P. aeruginosa before they went. Epidemiological typing used pulsed-field gel electrophoresis of the P. aeruginosa isolates was performed. The typing results showed that the 5 cystic fibrosis patients who were free of P. aeruginosa in their sputum prior to the winter camp had acquired P. aeruginosa isolates identical to the P. aeruginosa strains isolated from the other 17 cystic fibrosis patients. This constitutes a cross-colonization rate of 100%, the highest rate ever detected among patients with cystic fibrosis. We conclude that separate holiday camps based on the infection status of the patients with cystic fibrosis are necessary to avoid cross-infection of patients not infected with P. aeruginosa. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10686037     DOI: 10.1002/(sici)1099-0496(200003)29:3<177::aid-ppul4>3.0.co;2-u

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  24 in total

Review 1.  Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and Pandoraea spp.

Authors:  Andrew M Jones; A Kevin Webb
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

2.  Segregation is good for patients with cystic fibrosis.

Authors:  Steven Conway
Journal:  J R Soc Med       Date:  2008-07       Impact factor: 5.344

Review 3.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

4.  Heterogeneity of Pseudomonas aeruginosa in Brazilian cystic fibrosis patients.

Authors:  S Silbert; A L Barth; H S Sader
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

5.  Genome-wide transcriptional profiling of the steady-state response of Pseudomonas aeruginosa to hydrogen peroxide.

Authors:  Prabhakar Salunkhe; Tanja Töpfer; Jan Buer; Burkhard Tümmler
Journal:  J Bacteriol       Date:  2005-04       Impact factor: 3.490

6.  Rehabilitation Programs for Cystic Fibrosis - View from a CF Center.

Authors:  M Griese; P Busch; D Caroli; B Mertens; C Eismann; M Harari; H Staudter; M Kappler
Journal:  Open Respir Med J       Date:  2010-01-07

7.  Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross infection outbreak.

Authors:  A M Jones; J R W Govan; C J Doherty; M E Dodd; B J Isalska; T N Stanbridge; A K Webb
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

Review 8.  Infection control in cystic fibrosis.

Authors:  Lisa Saiman; Jane Siegel
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

9.  Pulmonary outcome differences in U.S. and French cystic fibrosis cohorts diagnosed through newborn screening.

Authors:  Aimee C Walsh; Gilles Rault; Zhanhai Li; Virginie Scotet; Ingrid Duguépéroux; Claude Férec; Michel Roussey; Anita Laxova; Philip M Farrell
Journal:  J Cyst Fibros       Date:  2009-11-18       Impact factor: 5.482

10.  Association between mucoid Pseudomonas infection and bronchiectasis in children with cystic fibrosis.

Authors:  Philip M Farrell; Jannette Collins; Lynn S Broderick; Michael J Rock; Zhanhai Li; Michael R Kosorok; Anita Laxova; William M Gershan; Alan S Brody
Journal:  Radiology       Date:  2009-08       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.